The current price of RXO is $27.88 — it has decreased by 1.83% since the previous close. Data as of Nov 5, 2026.
RXO is up 1.31% over the past week, down 2.69% over the past month and up 58.23% over the past year. The price is above its 200-day moving average of $21.24.
Analysts' average 12-month price target for RXO is $26.11, which implies 6.35% downside from the current price. Individual estimates range from $18.00 to $31.00.
Of the 18 analysts covering RXO, Inc., 1 rates it a strong buy, 2 rate it a buy and 15 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
RXO, Inc. has a market capitalization of $4.6B. The company belongs to the Industrials sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, RXO, Inc. posted earnings of $0.09 per share against an estimate of $0.07864, beating expectations by 14.45%. Upcoming reports are listed in the earnings calendar.
RXO, Inc. reported revenue of $1.87B in its most recent quarter, which has increased by 31.67% compared with the same quarter a year earlier. Analysts had expected $1.82B.
RXO, Inc. has not paid any dividends over the past year.
Companies most comparable to RXO, Inc. include FTAI Aviation Ltd., Matson, Inc., Hafnia Limited, Corporacion America Airports S.A. and McGrath RentCorp.
In the latest trading session RXO moved between $27.74 and $28.44, a range of 2.51% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of RXO, Inc. shows a neutral rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for RXO, Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks RXO has traded between $10.43 and $29.90. The current price is 6.76% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.